Fermion, a wholly owned subsidiary of Orion Corporation (Finland), is a CDMO specializing in developing, manufacturing, and marketing small molecule Active Pharmaceutical Ingredients (APIs), including HPAPIs, cytotoxics, steroids, generics, and controlled substances. Together with its parent Orion, it offers integrated contract development and manufacturing services for both drug substances and drug products, covering the full lifecycle from preclinical to commercial scale. FDA-approved since 1979 and EMA-approved since 1971.
Small molecule API manufacturing with deep expertise in HPAPIs, cytotoxics, steroids, and controlled substances. Capabilities include process optimization, crystallization, particle engineering, impurity control (nitrosamines), and finished dosage form CMO services (semisolids, transdermal/topical gels). Fully automated GMP facilities reduce labor by 15-20%.
2 sites worldwide
No reviews available yet.
No documents available.